Friday, March 29, 2019
The purpose of this transmittal is to introduce Policy Number: HCDMA-19-001 which removes the Prior Authorization requirements for Buprenorphine containing drug products and Vivitrol.
Public Notice: Due to the MMIS conversion the last provider payment from Conduent was issued on February 27. There will be no payment issued on March 6, and the first post‑conversion payment will be issued on March 13. For more information visit https://medicaid.dc.gov/
The purpose of this transmittal is to introduce Policy Number: HCDMA-19-001 which removes the Prior Authorization requirements for Buprenorphine containing drug products and Vivitrol.